4.90 USD
↘ 1.09 (18.27%)AT CLOSE (11:59 AM EDT)
Adial Pharmaceuticals, Inc
ADILNASDAQ • USD
4.96
↗ 0.06 (1.22%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
4.96
↗ 0.06 (1.22%)
Market: CLOSED
Adial Pharmaceuticals, Inc (ADIL) trades at $4.90 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (150.6%) and a bullish Golden Cross on the moving averages. On the valuation side, ADIL appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 11, 2026.
Open?$6.06
High?$6.11
Low?$4.80
Prev. Close?$6.00
Volume?108.5K
Avg. Volume?74.7K
VWAP?$5.31
Rel. Volume?1.45x
Bid / Ask
Bid?$4.89 × 300
Ask?$5.62 × 100
Spread?$0.73
Midpoint?$5.26
Valuation & Ratios
Market Cap?17.6M
Shares Out?2.6M
Float?2.1M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?-0.46
EPS?-$19.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.13Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?11.58%High
Short Interest?244.7K
Days to Cover?3.1
Free Float2.1M
Avg Daily Volume79.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?5.63Strong
Quick Ratio?5.63Strong
Cash Ratio?5.61Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.46CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?150.6%STRONG▾
Peers50
S&P97
ROA?-198.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11132939
Enterprise Value?$-11109776
Fundamentals ratios updated end of day